Click to request a meeting during J.P. Morgan Healthcare (8th – 11th Jan 2018)

Ibex™ from Lonza is an innovative new biological manufacturing and development concept, providing responsive capability from late discovery to clinical and commercial manufacture. Ibex™ solutions cover any technology platform, and are tailored to fit your evolving needs, improving time-to-market and simplifying your value chain. Because everyone has a different mountain to climb.

ibex on images

Introducing Ibex™ From Lonza

The path to market of a modern medicine is complex and uncertain. Today's biopharma companies must invest in technically challenging processes, from drug substance to drug product, while maintaining multiple partners and ensuring quality and regulatory compliance across that continuum.

At the same time, they must be able to respond to market and regulatory pressures, to synchronize production capability with clinical success.

Ibex is a campus of five manufacturing complexes that provides biopharma customers with agile capability at every stage of development and manufacture. Ibex™ solutions are technology agnostic and available with innovative, flexible ownership options, to help simplify the value chain and control capex.

Materials available for download on this page provide more information about Ibex™ solutions and Ibex campus.

Launch Brochure

Download the brochure to learn in depth about Ibex–The Agile Advantage™.

Download Here

Press Kit

Download the press release and imagery, for members of the press.

DOWNLOAD HERE

Contact Us

Request a meeting during J.P. Morgan Healthcare (9th - 11th Jan 2018).

GET IN TOUCH